Table 2. Role of p53 isoforms in human cancers.
| Cancer | Isoform | Observation | Ref. |
|---|---|---|---|
| Breast cancer | Δ133p53α | Overexpression | 33 |
| p53β | Loss of expression | 33,78 | |
| p53γ | Loss of expression Prognosis of mutp53/p53γ as good as wtp53 | 33,79 | |
| Acute myeloid leukaemia | p53β/γ | Increased expression in response to chemotherapy | 78 |
| Ovarian cancer | p53β | Serous and poorly differentiated tumours/worse recurrence-free and overall survival | 77 |
| Δ40p53 | Improved recurrence-free survival | 74 | |
| Li–Fraumeni syndrome | Δ40p53 | G-quadruplex structure overlapping TP53 PIN3/early age at first cancer diagnosis in patients carrying A1A1 compared with patients carrying A1A2 | 72 |